Science & Statistics for Life

The Charlotte Lozier Institute is committed to bringing the power of science, medicine, and research to bear in life-related policy making, media, and cultural debates.

Sign up to receive email updates from the Charlotte Lozier Institute.

As the education and research arm of the Susan B. Anthony List, our institute gathers the latest scientific and statistical information to protect human life – at all stages and conditions of dependency.

dimond-icon

Research

CLI brings together physicians, sociologists, statisticians, and policy researchers to do both original and interpretative research on a wide range of life issues.

Latest Article

Sex-Selection Abortion: The Real War on Women

View All

From the Blog

Keep up with the latest on our life-related research, public policy, and media.

  • An Outstanding History of the Pre-Roe Pro-life Movement

    The history of the pro-life movement has received precious little attention from either journalists or academics. In 2014, Dr. and Mrs. John C. Willke published Abortion and the Pro-Life Movement: An Inside View which is the first truly comprehensive history of the modern pro-life movement. Their book first explores the history of pro-life activism before Roe v. Wade and then devotes a chapter to every year after 1973. This year, Daniel K. Williams, associate professor of history at the University of West Georgia, published Defenders of the Unborn: The Pro-Life Movement Before Roe v. Wade, a helpful augmentation to the Willke’s book.

    Keep Reading
  • Bicameral Congressional Letter Demands Transparency from FDA

    Yesterday 75 members of Congress, led by Rep. Chris Smith of New Jersey and Sen. James Lankford of Oklahoma, sent a letter to the Commissioner of the Food and Drug Administration demanding answers to questions about the FDA’s surprise approval of relaxed protocols for the distribution of the abortion-inducing drug regimen known as Mifeprex. The changes, announced on March 30, significantly increase the duration of pregnancy at which the drug regimen may be administered, raising it from 49 days (7 weeks) from the last menstrual period (LMP) to 70 days (10 weeks) post-LMP.

    Keep Reading
  • New CLI Scholar to Testify at “Pricing of Fetal Tissue” Congressional Hearing

    On April 20, the U.S. House of Representatives’ Select Investigative Panel on Infant Lives will hold a hearing on “The Pricing of Fetal Tissue” in response to information brought forth by the Center for Medical Progress’ undercover video exposé. Charlotte Lozier Institute’s new associate scholar Catherine Glenn Foster, J.D. has been invited to testify as an attorney on the federal statutes governing fetal tissue research. Below is a preview of her testimony.

    Keep Reading
dimond-icon

Donate

We invite you to partner with us as we seek to build a society where the “least of these” among us are treasured and protected.

Become a Founding Member of the Charlotte Lozier Institute by making a tax-deductible donation today.